 |
|
|
Carbetocin
|
|
| Systematic (IUPAC) name | |
| (2S)-1-[(3S,6S,9S,12S,15S)-12-[(2S)-butan-2-yl]- 9-(2-carbamoylethyl)-6-(carbamoylmethyl)-15- [(4-hydroxyphenyl)methyl]-16-methyl-5,8,11,14,17- pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane- 3-carbonyl]-N-[(1S)-1-(carbamoylmethylcarbamoyl)- 3-methyl-butyl]pyrrolidine-2-carboxamide |
|
| Identifiers | |
| CAS number | 37025-55-1 |
| ATC code | H01BB03 |
| PubChem | 71715 |
| Chemical data | |
| Formula | C45H69N11O12S |
| Mol. mass | 988.162 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 80% (IM) |
| Metabolism | ? |
| Half life | 40 minutes |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Intravenous, intramuscular |
Carbetocin (Duratocin) is an obstetric drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin, such as contraction of the uterus.
Carbetocin is available in Canada and the United Kingdom, but not in the United States.
See also
References
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (August 2009) |
External links
- Carbetocin - Drugs.com
|
|||||||||||||||||||||||||||||
|
||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
